Rachel D Jacobson

Title: Rachel D. Jacobson: Innovator in Therapeutic Antibodies

Introduction

Rachel D. Jacobson is a prominent inventor based in Belmont, California. She has made significant contributions to the field of therapeutic antibodies, particularly in the development of IL-6 antibodies and their applications in treating various diseases. Her innovative work has the potential to impact the medical community positively.

Latest Patents

Rachel holds a patent for "IL-6 antibodies and fusion constructs and conjugates thereof." This invention provides antagonizing antibodies that bind to IL-6, fusion proteins with VEGF Trap, and conjugates of either. The anti-IL-6 antibodies can be used therapeutically alone or in combination with other treatments for diseases. She has 1 patent to her name, showcasing her expertise in this specialized area.

Career Highlights

Rachel is currently employed at Kodiak Sciences Inc., where she continues to advance her research and development efforts. Her work at the company focuses on innovative solutions in the field of biotechnology, particularly in therapeutic applications.

Collaborations

Throughout her career, Rachel has collaborated with notable colleagues, including Fernando Corrêa and Hong Liang. These partnerships have contributed to her success and the advancement of her research initiatives.

Conclusion

Rachel D. Jacobson is a trailblazer in the field of therapeutic antibodies, with a focus on IL-6 antibodies and their potential applications. Her contributions to the industry are noteworthy, and her work continues to inspire advancements in medical treatments.